NHS patients denied new Alzheimer’s drugs
The National Institute for Health and Care Excellence (NICE) has today issued final decisions on lecanemab and donanemab, ruling that neither drug will be available on the NHS in England and Wales.
Continue reading this article about NHS patients denied new Alzheimer’s drugs
by Alzheimer's Research UK
NHS Forums - For daily discussion by NHS Staff.

The National Institute for Health and Care Excellence (NICE) has today issued final decisions on lecanemab and donanemab, ruling that neither drug will be available on the NHS in England and Wales.
Continue reading this article about NHS patients denied new Alzheimer’s drugs
by Alzheimer's Research UK
NHS Forums - For daily discussion by NHS Staff.